Abcontek Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 5

Abcontek General Information

Description

Developer of antibody-based novel therapeutics designed to develop drugs. The company develops drugs for infectious diseases, fibrosis, skin disease, ocular disease, organ transplant rejection, and autoimmune diseases, enabling patients to save their lives from diseases without existing therapeutics.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Samsung Cancer Research Building
  • Suite 203-1 103 Deahak-ro, Jongno-gu
  • Seoul, 03080
  • South Korea
+82
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Samsung Cancer Research Building
  • Suite 203-1 103 Deahak-ro, Jongno-gu
  • Seoul, 03080
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Abcontek Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 01-Dec-2019 Completed Pre-Clinical Trials
2. Early Stage VC 29-Nov-2017 Completed Pre-Clinical Trials
1. Seed Round 01-Jul-2015 Completed Pre-Clinical Trials
To view Abcontek’s complete valuation and funding history, request access »

Abcontek Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Hana Financial Group Holding Company Minority
J-ONE Capital Invest Venture Capital Minority
MEPartners Venture Capital Minority
CJ Investment Corporate Venture Capital Minority
Young Science Corporation Minority
To view Abcontek’s complete investors history, request access »

Abcontek FAQs

  • When was Abcontek founded?

    Abcontek was founded in 2013.

  • Where is Abcontek headquartered?

    Abcontek is headquartered in Seoul, South Korea.

  • What industry is Abcontek in?

    Abcontek’s primary industry is Drug Discovery.

  • Is Abcontek a private or public company?

    Abcontek is a Private company.

  • What is Abcontek’s current revenue?

    The current revenue for Abcontek is .

  • How much funding has Abcontek raised over time?

    Abcontek has raised $181K.

  • Who are Abcontek’s investors?

    Hana Financial Group, J-ONE Capital Invest, MEPartners, CJ Investment, and Young Science have invested in Abcontek.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process